Evidence map›Paper›PMID 30276008›Full record

ArticleACS catalysis2018

3-Aryl-2,5-Dihydropyrroles via Catalytic Carbonyl-Olefin Metathesis.

Emilia J Groso, Alexander N Golonka, Ryan A Harding, Brandon W Alexander, Taylor M Sodano, Corinna S Schindler

Abstract read
In one paragraph

Article in ACS catalysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Carbonyl-Olefin Metathesis.Chemical reviews · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Synthesis of 2ACS catalysis · 2019
    Article
  14. Catalyst Behavior in Metal-Catalyzed Carbonyl-Olefin Metathesis.Journal of the American Chemical Society · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. GaClOrganic letters · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emilia J GrosoDepartment of Chemistry, Willard Henry Dow Laboratory, University of Michigan, 930 North University Ave., Ann Arbor, Michigan 48109, United States.
Alexander N GolonkaDepartment of Chemistry, Willard Henry Dow Laboratory, University of Michigan, 930 North University Ave., Ann Arbor, Michigan 48109, United States.
Ryan A HardingDepartment of Chemistry, Willard Henry Dow Laboratory, University of Michigan, 930 North University Ave., Ann Arbor, Michigan 48109, United States.
Brandon W AlexanderDepartment of Chemistry, Willard Henry Dow Laboratory, University of Michigan, 930 North University Ave., Ann Arbor, Michigan 48109, United States.
Taylor M SodanoDepartment of Chemistry, Willard Henry Dow Laboratory, University of Michigan, 930 North University Ave., Ann Arbor, Michigan 48109, United States.
Corinna S SchindlerDepartment of Chemistry, Willard Henry Dow Laboratory, University of Michigan, 930 North University Ave., Ann Arbor, Michigan 48109, United States.

Funding

Iron-Catalyzed Metathesis and Carbocation Cyclization Reactions-SupplementR01GM118644 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHINDLER, CORINNA STEFANIE · 2016 to 2020
$1.7M
NIGMS NIH HHS R01 GM118644
6 · The paper itself

Abstract

Herein, we describe the development of a synthetic strategy towards chiral 3-pyrrolines based on the design principle of iron(III)-catalyzed carbonyl-olefin metathesis. This approach takes advantage of commercially available amino acids as chiral pool reagents and FeCl

Indexed as

amino acidscarbonyl-olefin metathesisiron(III) chlorideLewis acid catalysispyrrolines

Identifiers

PMID30276008
PMCPMC6162066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.